254 related articles for article (PubMed ID: 37031806)
21. Mean pulmonary arterial pressure as a prognostic indicator in connective tissue disease associated with interstitial lung disease: a retrospective cohort study.
Takahashi K; Taniguchi H; Ando M; Sakamoto K; Kondoh Y; Watanabe N; Kimura T; Kataoka K; Suzuki A; Ito S; Hasegawa Y
BMC Pulm Med; 2016 Apr; 16(1):55. PubMed ID: 27094018
[TBL] [Abstract][Full Text] [Related]
22. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
23. Comparison between the ATS/ERS/JRS/ALAT criteria of 2011 and 2018 for Usual Interstitial Pneumonia on HRCT: a cross-sectional study.
Wuyts LL; Camerlinck M; De Surgeloose D; Vermeiren L; Ceulemans D; Clukers J; Slabbynck H
Br J Radiol; 2021 Apr; 94(1120):20201159. PubMed ID: 33539231
[TBL] [Abstract][Full Text] [Related]
24. [Interstitial pneumonia with autoimmune features: monocentric prospective study].
Akulkina LA; Shchepalina AA; Moiseev AS; Brovko MY; Sholomova VI; Moiseev SV
Ter Arkh; 2023 Apr; 95(3):224-229. PubMed ID: 37167143
[TBL] [Abstract][Full Text] [Related]
25. Serum Rcn3 level is a potential diagnostic biomarker for connective tissue disease-associated interstitial lung disease and reflects the severity of pulmonary function.
Ding F; Yang L; Wang Y; Wang J; Ma Y; Jin J
BMC Pulm Med; 2023 Feb; 23(1):68. PubMed ID: 36800954
[TBL] [Abstract][Full Text] [Related]
26. Validation of Proposed Criteria for Progressive Pulmonary Fibrosis.
Pugashetti JV; Adegunsoye A; Wu Z; Lee CT; Srikrishnan A; Ghodrati S; Vo V; Renzoni EA; Wells AU; Garcia CK; Chua F; Newton CA; Molyneaux PL; Oldham JM
Am J Respir Crit Care Med; 2023 Jan; 207(1):69-76. PubMed ID: 35943866
[No Abstract] [Full Text] [Related]
27. Management of progressive pulmonary fibrosis associated with connective tissue disease.
Molina-Molina M; Castellví I; Valenzuela C; Ramirez J; Rodríguez Portal JA; Franquet T; Narváez J
Expert Rev Respir Med; 2022 Jul; 16(7):765-774. PubMed ID: 35912842
[TBL] [Abstract][Full Text] [Related]
28. Connective Tissue Disease Associated Interstitial Lung Disease.
Matson SM; Demoruelle MK
Rheum Dis Clin North Am; 2024 Aug; 50(3):423-438. PubMed ID: 38942578
[TBL] [Abstract][Full Text] [Related]
29. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ?
de Lauretis A; Veeraraghavan S; Renzoni E
Chron Respir Dis; 2011; 8(1):53-82. PubMed ID: 21339375
[TBL] [Abstract][Full Text] [Related]
30. Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study.
Sambataro G; Libra A; Spicuzza L; Palmucci S; Conti P; Spagnolo E; Colaci M; Malatino L; Orlandi M; Sambataro D; Vancheri C
Respiration; 2023; 102(6):405-415. PubMed ID: 37231870
[TBL] [Abstract][Full Text] [Related]
31. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis.
Joy GM; Arbiv OA; Wong CK; Lok SD; Adderley NA; Dobosz KM; Johannson KA; Ryerson CJ
Eur Respir Rev; 2023 Mar; 32(167):. PubMed ID: 36889782
[TBL] [Abstract][Full Text] [Related]
32. Interstitial Lung Disease: A Review.
Maher TM
JAMA; 2024 May; 331(19):1655-1665. PubMed ID: 38648021
[TBL] [Abstract][Full Text] [Related]
33. Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study.
Chan C; Ryerson CJ; Dunne JV; Wilcox PG
BMC Pulm Med; 2019 Oct; 19(1):192. PubMed ID: 31672127
[TBL] [Abstract][Full Text] [Related]
34. Lung-dominant connective tissue disease among patients with interstitial lung disease: prevalence, functional stability, and common extrathoracic features.
Pereira DA; Dias OM; Almeida GE; Araujo MS; Kawano-Dourado LB; Baldi BG; Kairalla RA; Carvalho CR
J Bras Pneumol; 2015; 41(2):151-60. PubMed ID: 25972968
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease.
Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ;
Respirology; 2022 Oct; 27(10):854-862. PubMed ID: 35652240
[TBL] [Abstract][Full Text] [Related]
36. Antinuclear antibodies in interstitial lung disease: Prevalence and clinical significance.
Ghrairi N; Aouadi S; Elhechmi YZ; Ben Saad S; Ben Ali I; Yalaoui S
Tunis Med; 2019 Nov; 97(11):1240-1245. PubMed ID: 32173825
[TBL] [Abstract][Full Text] [Related]
37. Interstitial lung disease in connective tissue disease--mechanisms and management.
Wells AU; Denton CP
Nat Rev Rheumatol; 2014 Dec; 10(12):728-39. PubMed ID: 25266451
[TBL] [Abstract][Full Text] [Related]
38. Treatment of connective tissue disease-associated interstitial lung disease: the pulmonologist's point of view.
Koo SM; Uh ST
Korean J Intern Med; 2017 Jul; 32(4):600-610. PubMed ID: 28704913
[TBL] [Abstract][Full Text] [Related]
39. [Interstitial lung disease in connective tissue disorders].
Carmier D; Diot É; Guilleminault L; Marchand-Adam S
Rev Prat; 2014 Sep; 64(7):941-5. PubMed ID: 25362775
[TBL] [Abstract][Full Text] [Related]
40. Histopathological significance of connective tissue disease-associated interstitial lung disease in transbronchial lung cryobiopsy specimens.
Katsuragawa H; Sumiyoshi S; Ikegami N; Hashimoto S; Hajiro T; Taguchi Y; Kobashi Y; Haga H; Yoshizawa A
Pathol Res Pract; 2024 Feb; 254():155078. PubMed ID: 38262268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
